• +1-646-491-9876
    • +91-20-67278686

    Search

    Post-Operative Pain - Pipeline Review, H1 2017

    Post-Operative Pain - Pipeline Review, H1 2017

    • Report Code ID: RW0001689379
    • Category Healthcare
    • No. of Pages 187
    • Publication Month Feb-17
    • Publisher Name Global Markets Direct
    Report Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H1 2017, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.

    Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 1, 9, 16, 10, 13, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 1 molecules, respectively.

    Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Report Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System).
    - The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents 2
    List of Tables 4
    List of Figures 6
    Introduction 7
    Publisher Report Coverage 7
    Post-Operative Pain - Overview 8
    Post-Operative Pain - Therapeutics Development 9
    Pipeline Overview 9
    Pipeline by Companies 10
    Pipeline by Universities/Institutes 14
    Products under Development by Companies 15
    Products under Development by Universities/Institutes 19
    Post-Operative Pain - Therapeutics Assessment 20
    Assessment by Target 20
    Assessment by Mechanism of Action 23
    Assessment by Route of Administration 26
    Assessment by Molecule Type 28
    Post-Operative Pain - Companies Involved in Therapeutics Development 30
    AcelRx Pharmaceuticals Inc 30
    Adynxx Inc 30
    AngioChem Inc 31
    Aoxing Pharmaceutical Company Inc 31
    AskAt Inc 31
    Boehringer Ingelheim GmbH 32
    Camurus AB 33
    Cara Therapeutics Inc 33
    Colby Pharmaceutical Company 34
    Cytogel Pharma LLC 34
    Dompe Farmaceutici SpA 35
    DURECT Corp 35
    Eupraxia Pharmaceuticals Inc 36
    EyeGate Pharmaceuticals Inc 36
    Fujimoto Pharmaceutical Corp 37
    Grunenthal GmbH 37
    GW Pharmaceuticals Plc 38
    Heron Therapeutics Inc 38
    Immupharma Plc 39
    Innocoll AG 39
    INSYS Therapeutics Inc 40
    iX Biopharma Ltd 40
    Laboratorios Del Dr Esteve SA 41
    Lipocure Ltd 41
    Liquidia Technologies Inc 42
    Medtronic Plc 42
    Novartis AG 43
    Orbis Biosciences Inc 43
    Orion Oyj 44
    Pacira Pharmaceuticals Inc 44
    PainReform Ltd 45
    Pharmazz Inc 45
    PhytoHealth Corp 46
    PixarBio Corp 46
    Proteus SA 47
    Recro Pharma Inc 47
    Relmada Therapeutics Inc 48
    Serina Therapeutics Inc 48
    SteadyMed Therapeutics Inc 49
    Teikoku Pharma USA Inc 49
    The Medicines Company 50
    Trevena Inc 50
    Post-Operative Pain - Drug Profiles 51
    (bupivacaine hydrochloride + meloxicam) ER - Drug Profile 51
    (buprenorphine hydrochloride + granisetron hydrochloride) ER - Drug Profile 54
    A-100 - Drug Profile 55
    ANG-2002 - Drug Profile 56
    ARX-04 - Drug Profile 57
    AYX-1 - Drug Profile 64
    BI-1026706 - Drug Profile 67
    bupivacaine hydrochloride - Drug Profile 69
    bupivacaine hydrochloride - Drug Profile 70
    bupivacaine hydrochloride - Drug Profile 71
    bupivacaine hydrochloride - Drug Profile 72
    bupivacaine hydrochloride SR - Drug Profile 74
    bupivacaine hydrochloride SR - Drug Profile 79
    buprenorphine hydrochloride - Drug Profile 80
    CAM-2048 - Drug Profile 81
    carbamazepine - Drug Profile 82
    CPC-111 - Drug Profile 83
    CPC-123 - Drug Profile 84
    Cyt-1010 - Drug Profile 85
    dexamethasone acetate - Drug Profile 87
    dexmedetomidine hydrochloride - Drug Profile 92
    DF-2755A - Drug Profile 93
    difelikefalin - Drug Profile 94
    ECP-1014 - Drug Profile 103
    fadolmidine hydrochloride - Drug Profile 104
    fentanyl - Drug Profile 105
    gonyautoxin - Drug Profile 106
    grapiprant - Drug Profile 107
    HTX-009 - Drug Profile 109
    HYLP-002 - Drug Profile 110
    IPP-102199 - Drug Profile 111
    ketamine hydrochloride - Drug Profile 112
    ketorolac tromethamine - Drug Profile 114
    lacosamide - Drug Profile 115
    levorphanol tartrate ER - Drug Profile 116
    MDT-10013 - Drug Profile 118
    meloxicam - Drug Profile 119
    meloxicam ER - Drug Profile 123
    MR-309 - Drug Profile 124
    nabiximols - Drug Profile 126
    nalbuphine hydrochloride - Drug Profile 133
    neosaxitoxin - Drug Profile 134
    oliceridine - Drug Profile 136
    oxethazaine - Drug Profile 141
    PMZ-2010 - Drug Profile 142
    RBM-004 - Drug Profile 144
    ropivacaine - Drug Profile 145
    ropivacaine ER - Drug Profile 146
    SAF-312 - Drug Profile 147
    SER-226 - Drug Profile 148
    Small Molecule for Post-Operative Pain - Drug Profile 149
    sufentanil citrate - Drug Profile 150
    tapentadol hydrochloride - Drug Profile 158
    tilidine hydrochloride - Drug Profile 160
    tramadol hydrochloride - Drug Profile 161
    tramadol hydrochloride ER - Drug Profile 162
    URB-937 - Drug Profile 163
    VVZ-149 - Drug Profile 164
    Post-Operative Pain - Dormant Projects 165
    Post-Operative Pain - Discontinued Products 168
    Post-Operative Pain - Product Development Milestones 169
    Featured News & Press Releases 169
    Appendix 182
    Methodology 182
    Coverage 182
    Secondary Research 182
    Primary Research 182
    Expert Panel Validation 182
    Contact Us 182
    Disclaimer 183

    List of Tables

    Number of Products under Development for Post-Operative Pain, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1), H1 2017
    Products under Development by Companies, H1 2017 (Contd..2), H1 2017
    Products under Development by Companies, H1 2017 (Contd..3), H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H1 2017
    Post-Operative Pain - Pipeline by Adynxx Inc, H1 2017
    Post-Operative Pain - Pipeline by AngioChem Inc, H1 2017
    Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H1 2017
    Post-Operative Pain - Pipeline by AskAt Inc, H1 2017
    Post-Operative Pain - Pipeline by Boehringer Ingelheim GmbH, H1 2017
    Post-Operative Pain - Pipeline by Camurus AB, H1 2017
    Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H1 2017
    Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H1 2017
    Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H1 2017
    Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H1 2017
    Post-Operative Pain - Pipeline by DURECT Corp, H1 2017
    Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H1 2017
    Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H1 2017
    Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H1 2017
    Post-Operative Pain - Pipeline by Grunenthal GmbH, H1 2017
    Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H1 2017
    Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H1 2017
    Post-Operative Pain - Pipeline by Immupharma Plc, H1 2017
    Post-Operative Pain - Pipeline by Innocoll AG, H1 2017
    Post-Operative Pain - Pipeline by INSYS Therapeutics Inc, H1 2017
    Post-Operative Pain - Pipeline by iX Biopharma Ltd, H1 2017
    Post-Operative Pain - Pipeline by Laboratorios Del Dr Esteve SA, H1 2017
    Post-Operative Pain - Pipeline by Lipocure Ltd, H1 2017
    Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H1 2017
    Post-Operative Pain - Pipeline by Medtronic Plc, H1 2017
    Post-Operative Pain - Pipeline by Novartis AG, H1 2017
    Post-Operative Pain - Pipeline by Orbis Biosciences Inc, H1 2017
    Post-Operative Pain - Pipeline by Orion Oyj, H1 2017
    Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H1 2017
    Post-Operative Pain - Pipeline by PainReform Ltd, H1 2017
    Post-Operative Pain - Pipeline by Pharmazz Inc, H1 2017
    Post-Operative Pain - Pipeline by PhytoHealth Corp, H1 2017
    Post-Operative Pain - Pipeline by PixarBio Corp, H1 2017
    Post-Operative Pain - Pipeline by Proteus SA, H1 2017
    Post-Operative Pain - Pipeline by Recro Pharma Inc, H1 2017
    Post-Operative Pain - Pipeline by Relmada Therapeutics Inc, H1 2017
    Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H1 2017
    Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H1 2017
    Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H1 2017
    Post-Operative Pain - Pipeline by The Medicines Company, H1 2017
    Post-Operative Pain - Pipeline by Trevena Inc, H1 2017
    Post-Operative Pain - Dormant Projects, H1 2017
    Post-Operative Pain - Dormant Projects, H1 2017 (Contd..1), H1 2017
    Post-Operative Pain - Dormant Projects, H1 2017 (Contd..2), H1 2017
    Post-Operative Pain - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Post-Operative Pain, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Top 10 Routes of Administration, H1 2017
    Number of Products by Stage and Top 10 Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    AcelRx Pharmaceuticals Inc
    Adynxx Inc
    AngioChem Inc
    Aoxing Pharmaceutical Company Inc
    AskAt Inc
    Boehringer Ingelheim GmbH
    Camurus AB
    Cara Therapeutics Inc
    Colby Pharmaceutical Company
    Cytogel Pharma LLC
    Dompe Farmaceutici SpA
    DURECT Corp
    Eupraxia Pharmaceuticals Inc
    EyeGate Pharmaceuticals Inc
    Fujimoto Pharmaceutical Corp
    Grunenthal GmbH
    GW Pharmaceuticals Plc
    Heron Therapeutics Inc
    Immupharma Plc
    Innocoll AG
    INSYS Therapeutics Inc
    iX Biopharma Ltd
    Laboratorios Del Dr Esteve SA
    Lipocure Ltd
    Liquidia Technologies Inc
    Medtronic Plc
    Novartis AG
    Orbis Biosciences Inc
    Orion Oyj
    Pacira Pharmaceuticals Inc
    PainReform Ltd
    Pharmazz Inc
    PhytoHealth Corp
    PixarBio Corp
    Proteus SA
    Recro Pharma Inc
    Relmada Therapeutics Inc
    Serina Therapeutics Inc
    SteadyMed Therapeutics Inc
    Teikoku Pharma USA Inc
    The Medicines Company
    Trevena Inc

    Request for Sample

    Report Url http://www.reportsweb.com//post-operative-pain-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//post-operative-pain-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//post-operative-pain-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments